April 8 (Reuters) - BARD1 Life Sciences Ltd (BD1) :
- BARD1 AND SIENNA CANCER DIAGNOSTICS ANNOUNCE MERGER
- ENTERED INTO A MERGER IMPLEMENTATION AGREEMENT WITH SIENNA CANCER DIAGNOSTICS
- SIENNA SHAREHOLDERS WILL BE OFFERED 13 NEW SHARES IN BARD1 FOR EVERY 5 SHARES IN SIENNA
- UNDER DEAL, VALUES EACH SIENNA SHARE AT $0.061
- DEAL VALUES EACH SIENNA SHARE AT $0.061 PER SHARE & SIENNA AT ABOUT $23.7 MILLION ON FULLY DILUTED BASIS
- Forums
- ASX - By Stock
- News: SDX Bard1 Life Sciences And Sienna Cancer Diagnostics Announce Merger
April 8 (Reuters) - BARD1 Life Sciences Ltd (BD1) : BARD1 AND...
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SDX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online